A small clinical trial of vaporized cannabis for PTSD: suggestive results and directions for future study.
Trials September 9, 2023 Zach Walsh, Ian Mitchell, Kim Crosby et al.
The last few decades have seen increasing interest in the use of cannabis for post-traumatic stress disorder (PTSD). Recent attempts to evaluate the clinical efficacy of cannabis for PTSD were inconclusive and generalizability was limited by undesirable features of the study drug. The present clinical trial evaluated the effects of a commercially available chemovar that was delivered by...
DOI: 10.1186/s13063-023-07543-2 (opens in new tab)
Full text (opens in new tab)
PTSD
Medical cannabis
Plant medicine